Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1989 Sep;44(9):739–742. doi: 10.1136/thx.44.9.739

Infective respiratory exacerbations in young adults with cystic fibrosis: role of viruses and atypical microorganisms.

E L Ong 1, M E Ellis 1, A K Webb 1, K R Neal 1, M Dodd 1, E O Caul 1, S Burgess 1
PMCID: PMC462055  PMID: 2588211

Abstract

Thirty six adults with cystic fibrosis were studied over one year to determine the incidence of infection with respiratory viruses and atypical organisms. Nineteen patients entered the study during an acute exacerbation of respiratory symptoms with an increase in purulent sputum production, cough, or breathlessness accompanied by a fall in FEV1 (group 1); 17 patients entered when they were stable both clinically and in terms of lung function values (group 2). Group 1 patients had a mean of 2.6 (range 1-4) infective exacerbations during the year and group 2 patients a mean of 1.1 (0-2) exacerbations. Eleven patients developed serological evidence of viral (influenza virus A and B, cytomegalovirus, human rhinovirus 2, adenovirus) or Mycoplasma pneumoniae infection. There was no difference in seroconversion rates between group 1 (five patients) and group 2 (six patients). There was a weak association between viral seroconversion and the isolation of Pseudomonas aeruginosa from sputum, though this was not significant.

Full text

PDF
739

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANDERSEN D. H. Cystic fibrosis of the pancreas. J Chronic Dis. 1958 Jan;7(1):58–90. doi: 10.1016/0021-9681(58)90185-1. [DOI] [PubMed] [Google Scholar]
  2. Efthimiou J., Hodson M. E., Taylor P., Taylor A. G., Batten J. C. Importance of viruses and Legionella pneumophila in respiratory exacerbations of young adults with cystic fibrosis. Thorax. 1984 Feb;39(2):150–154. doi: 10.1136/thx.39.2.150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Freke A., Stott E. J., Roome A. P., Caul E. O. The detection of respiratory syncytial virus in nasopharyngeal aspirates: assessment, formulation, and evaluation of monoclonal antibodies as a diagnostic reagent. J Med Virol. 1986 Feb;18(2):181–191. doi: 10.1002/jmv.1890180210. [DOI] [PubMed] [Google Scholar]
  4. Grilli E. A., Smith A. J. The use of a radial haemolysis test for neuraminidase antibodies in the diagnosis of influenza A infection. J Hyg (Lond) 1983 Aug;91(1):147–156. doi: 10.1017/s0022172400060125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gross P. A., Ennis F. A., Gaerlan P. F., Denson L. J., Denning C. R., Schiffman D. A controlled double-blind comparison of reactogenicity, immunogenicity, and protective efficacy of whole-virus and split-product influenza vaccines in children. J Infect Dis. 1977 Nov;136(5):623–632. doi: 10.1093/infdis/136.5.623. [DOI] [PubMed] [Google Scholar]
  6. HUANG N. N., VAN LOON E. L., SHENG K. T. The flora of the respiratory tract of patients with cystic fibrosis of the pancreas. J Pediatr. 1961 Oct;59:512–521. doi: 10.1016/s0022-3476(61)80234-5. [DOI] [PubMed] [Google Scholar]
  7. Marks M. I. Respiratory viruses in cystic fibrosis. N Engl J Med. 1984 Dec 27;311(26):1695–1696. doi: 10.1056/NEJM198412273112610. [DOI] [PubMed] [Google Scholar]
  8. May J. R., Herrick N. C., Thompson D. Bacterial infection in cystic fibrosis. Arch Dis Child. 1972 Dec;47(256):908–913. doi: 10.1136/adc.47.256.908. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Petersen N. T., Høiby N., Mordhorst C. H., Lind K., Flensborg E. W., Bruun B. Respiratory infections in cystic fibrosis patients caused by virus, chlamydia and mycoplasma--possible synergism with Pseudomonas aeruginosa. Acta Paediatr Scand. 1981 Sep;70(5):623–628. doi: 10.1111/j.1651-2227.1981.tb05757.x. [DOI] [PubMed] [Google Scholar]
  10. Wang E. E., Prober C. G., Manson B., Corey M., Levison H. Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis. N Engl J Med. 1984 Dec 27;311(26):1653–1658. doi: 10.1056/NEJM198412273112602. [DOI] [PubMed] [Google Scholar]
  11. Wright P. F., Khaw K. T., Oxman M. N., Shwachman H. Evaluation of the safety of amantadine-HC1 and the role of respiratory viral infections in children with cystic fibrosis. J Infect Dis. 1976 Aug;134(2):144–149. doi: 10.1093/infdis/134.2.144. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES